Clinical trial

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

NCT01467323

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention biphasic insulin aspart Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention biphasic human insulin Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1998-04-01

PhasePHASE3

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

biphasic insulin aspartDRUG

biphasic human insulinDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

BerlinGermany2 DublinIreland2 HamburgGermany1 ViennaAustria1 MünchenGermany1 LeipzigGermany1 BirminghamUnited Kingdom1 GrazAustria1 UlmGermany1 NottinghamUnited Kingdom1 BernSwitzerland1 LeicesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01467323 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.